• Mianserin Hydrochloride in Psychiatric Research: Advanced Me

  2026-06-08

  Explore the multifaceted role of Mianserin HCl, a leading 5-HT2 receptor antagonist, in psychiatric disorder research. This article uncovers advanced mechanisms, translational benefits, and assay guidance distinct from prior literature.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-06-07

  The reference study demonstrates that phenothiazine compounds, including Perphenazine, enhance the antibacterial efficacy of macrophages by inducing reactive oxygen species (ROS) production and autophagy. These findings suggest a promising host-directed therapy approach against intracellular bacterial infections that may complement conventional antibiotics.

• Recombinant Mouse IFN-γ in Tumor Antigenicity and Immunother

  2026-06-06

  Explore how Recombinant Mouse IFN-γ empowers immunomodulatory cytokine research and advances tumor antigenicity studies. This article uniquely connects IFN-γ’s mechanistic role to the latest breakthroughs in metabolic immune escape, offering protocol insights and practical applications.

• Arrb2 Drives M2 Macrophage Polarization to Mitigate Hepatic

  2026-06-05

  This study uncovers a mechanistic pathway in which hepatocyte-expressed Arrb2 promotes M2 macrophage polarization and upregulates 6-ketoLCA, collectively ameliorating hepatic ischemia–reperfusion injury. These findings illuminate new metabolic and immunoregulatory targets for improving liver transplantation outcomes and guiding hepatic IRI research.

• Cyclic di-GMP in Biofilm and Immune Modulation Workflows

  2026-06-05

  This article delivers scenario-driven, evidence-based guidance for optimizing biofilm formation regulation and immune modulation research using Cyclic di-GMP (SKU B7839). Drawing on recent peer-reviewed findings and validated protocol parameters, it addresses practical challenges in assay reproducibility and product selection. APExBIO’s high-purity Cyclic di-GMP is highlighted for its reliability and performance in advanced biomedical workflows.

• Nose-to-Brain Rotigotine Nanoparticles for Parkinson’s Model

  2026-06-04

  The referenced study presents a novel intranasal delivery system for Rotigotine hydrochloride using chitosan nanoparticles, enabling efficient nose-to-brain targeting in both cellular and animal models of Parkinson’s disease. This approach addresses bioavailability limitations of oral formulations and demonstrates significant neuroprotection and motor function recovery, highlighting its translational potential for dopaminergic signaling research.

• Tamoxifen as a Versatile SERM: Beyond Breast Cancer Research

  2026-06-04

  Explore the multifaceted applications of tamoxifen, a selective estrogen receptor modulator, in research—covering its molecular actions, gene knockout utility, and emerging cross-domain insights. This article reveals advanced scientific perspectives and practical considerations distinct from prevailing content.

• HotStart Universal 2X Green qPCR Master Mix: Precision for G

  2026-06-03

  HotStart™ Universal 2X Green qPCR Master Mix delivers robust, antibody-mediated hot-start specificity and universal ROX compatibility, enabling high-throughput, reproducible gene expression quantification. Its performance shines in complex workflows, such as biomarker discovery in heterogeneous cancers, where assay precision and melt curve validation are paramount.

• Radioiodinated Balsalazide as a Selective Radiotracer for Ul

  2026-06-03

  This study introduces a robust protocol for the radioiodination of balsalazide, yielding a stable, highly selective radiotracer for imaging ulcerative colitis (UC) in mouse models. By optimizing radiochemical conditions, the authors achieve high colon-specific uptake and provide new opportunities for in vivo assessment of UC, addressing previous limitations in follow-up and specificity.

• DOT1L Inhibition Mitigates Renal Fibrosis via Epigenetic Mod

  2026-06-02

  This study demonstrates that selective inhibition of DOT1L, specifically using EPZ5676, can attenuate renal fibrosis by suppressing renal fibroblast activation and epithelial-mesenchymal transition (EMT). The findings underscore a novel epigenetic mechanism with implications for chronic kidney disease research and potential therapeutic targeting.

• Nose-to-Brain Rotigotine Nanoparticles for Parkinson’s Model

  2026-06-02

  This study demonstrates that chitosan nanoparticle-based nose-to-brain delivery of Rotigotine hydrochloride enhances neuronal uptake, neuroprotection, and behavioral recovery in Parkinson’s disease models. The findings highlight a significant advance in overcoming bioavailability barriers for dopaminergic therapies and provide groundwork for translational research in antiparkinsonian strategies.

• Cy5 NHS ester(Et): Technical Guidance for Protein Labeling

  2026-06-01

  Cy5 NHS ester(Et) is designed for covalent, water-soluble fluorescent labeling of primary amines in proteins, peptides, and related biomolecules, supporting applications such as immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is not suitable for ethanol-based workflows or for protocols that require long-term storage of working solutions. Immediate-use labeling with proper solubilization and storage is essential for consistent results.

• Super-Enhancer Hijacking of LINC01977 in Early LUAD Progress

  2026-06-01

  Zhang et al. uncover how super-enhancer-driven activation of LINC01977 lncRNA drives malignancy in early-stage lung adenocarcinoma via the canonical TGF-β/SMAD3 axis. Their integrative epigenetic approach highlights new therapeutic targets and experimental models for transcriptional coactivator inhibition in lung cancer research.

• Foretinib (GSK1363089): Advancing Quantitative Cancer Drug R

  2026-05-31

  Explore how Foretinib (GSK1363089) enables nuanced, quantitative evaluation of tumor cell growth inhibition and cell death in modern cancer research. This article uniquely integrates in vitro assay advances and protocol optimization for translational impact.

• 8-Chloroadenosine: Precision Nucleoside Analog in RNA Resear

  2026-05-30

  8-Chloroadenosine offers researchers unmatched precision in dissecting RNA metabolism and transcriptional regulation, especially in cancer models. Its high purity and robust inhibition profile make it an essential molecular biology reagent for advanced workflows.

445 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page